Workflow
贵州三力: 贵州三力制药股份有限公司2024年年度权益分派实施公告

Core Points - Guizhou Sanli Pharmaceutical Co., Ltd. has announced a cash dividend distribution plan, with a cash dividend of RMB 0.34 per share, totaling RMB 137,638,805.44 (including tax) for the participating shareholders [1][2][4] - The total number of shares participating in the distribution is 404,820,016 shares after excluding 4,982,200 shares that do not participate due to being held in a repurchase account [2][3] - The record date for the dividend distribution is June 25, 2025, with the ex-dividend date also set for June 26, 2025 [3][4] Dividend Distribution Details - The cash dividend will be distributed to shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [1][3] - The company will not issue bonus shares or increase capital through the dividend distribution, meaning the number of circulating shares will remain unchanged [2][3] - The reference price for the ex-dividend will be calculated based on the formula: (previous closing price - cash dividend) [2][3] Tax Implications - For individual shareholders holding shares for more than one year, the cash dividend is exempt from personal income tax, resulting in an actual distribution of RMB 0.34 per share [6] - For shares held for less than one year, the tax will be calculated upon transfer, with a 20% tax rate applicable for holdings of one month or less [6][7] - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net cash dividend of RMB 0.306 per share [7][8]